This is a match-making section for JPIAMR 14th call - Disrupting drug Resistance Using Innovative Design (DRUID).
Human Health
in silico, in vitro, in vivo
structural biology; macromolecular crystallography; antibiotic resistance; antibacterial drug design; Pseudomonas aeruginosa
Our group develops novel inhibition strategies against enzymes of pathogenic origin. We apply a broad range of methods from the intersection of microbiology, biochemistry, and biophysics, including macromolecular crystallography, Cryo-EM single particle analysis, ITC, and high-throughput enzyme kinetics. Our current studies concern: 1. Structural enzymology of bacterial enzymes involved in methylation reactions. 2. Development of species-specific inhibitors targeting the enzymes from pathogenic microorganisms. 3. High-throughput macromolecular crystallography. 4. Crystallographic studies of biologically active small molecules. 5. X-ray diffraction studies of non-crystalline (bio)materials.
We would like to join the rational antibacterial drug design project that requires the implementation of structural biology and biophysics approaches.
Submitted on 2022-05-26 14:44:31
« Return to the partner search tool